���Ҵ�ý�ƽ������

Chemical and Biological Engineering PhD Student Bruce Kirkpatrick was honored with the 2025 Outstanding Dissertation Award. His hydrogel research supports technologies that enable 3D cell culture for tissue engineering and disease modeling, as well as acellular biomaterials for applications like controlled release of drugs or vaccines.

A new ���Ҵ�ý�ƽ������ study published in the Proceedings of the National Academy of Sciences reveals how electric fields control nanoparticle movement through porous materials, enabling independent control of speed and direction. This finding could advance nanorobot technologies for applications like tumor detection, drug delivery and environmental cleanup of toxic chemicals.

The win came at the American Institute of Chemical Engineers’ international Chem-E-Car competition in Boston, where ���Ҵ�ý�ƽ������ poster stood out among 56 teams.

Assistant Professor Ankur Gupta, the study’s lead researcher, and his team have developed a way to simulate natural animal patterns, including their imperfections. The findings could lead to new materials that turn to camouflage on demand.

The project, like something straight out of a health sci-fi movie, combines RNA-based gene therapy with tiny microrobots for drug transport to help treat acute respiratory distress syndrome (ARDS).

Adding to a growing list of honors, Assistant Professor Ankur Gupta has been awarded the Royal Society of Chemistry’s 2025 Soft Matter Lectureship — a prestigious recognition of outstanding early-career researchers in the field.

Co-organized by Professor Mike Toney, the 2025 Front Range Electrochemistry Workshop (FREW) broadly addressed electrochemical science, with this year’s focus on batteries reflecting their growing importance to everything from electric vehicles to renewable energy infrastructure.

���Ҵ�ý�ƽ������ researchers, led by Ted Randolph, a professor in the Department of Chemical and Biological Engineering, have developed a groundbreaking temperature-stable rabies vaccine that combines multiple doses into a single shot—an innovation that could vastly improve global access to life-saving immunization.

See is advancing new technologies to boost the performance of future sustainable batteries.

A gecko-inspired technology developed by the Shields Lab, in collaboration with doctors at the University of Colorado Anschutz Medical Campus, uses a specially designed material that adheres to tumors inside the body and steadily releases chemotherapy drugs over several days—potentially allowing for fewer but longer-lasting therapies.